US 10064846
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
granted A61KA61K31/155A61K31/426
Quick answer
US patent 10064846 (Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator) held by VTV THERAPEUTICS LLC expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VTV THERAPEUTICS LLC
- Grant date
- Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/155, A61K31/426, A61P, A61P3/00